Thoratec, now a part of St. Jude Medical

Thoratec, now part of St. Jude Medical, is a medical device company that specializes in circulatory support devices, particularly ventricular assist devices (VADs) for patients with severe heart failure. Founded in 1976 in California, Thoratec has a strong history of innovation and was a pioneer in obtaining FDA approval for VADs intended for permanent use in patients who are not candidates for heart transplants. The company's core products include mechanical pumps that support heart function and blood flow, serving as a bridge to heart transplantation or as long-term therapy for patients ineligible for transplant. Thoratec's VAD System was the first FDA-approved device for comprehensive heart support. The company also developed advanced biocompatible materials to enhance device safety and performance. With the acquisition of Thermo Cardiosystems, Thoratec expanded its offerings to include the HeartMate Left Ventricular Assist System, further solidifying its position in the artificial heart device market.

• Employees 260
• Founded 1976
• Annual Revenue $473900000
• Total Funding $50000000